Naidenko OV - Search Results

1

Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.

Naidenko OV, Maher JK, Ernst WA, Sakai T, Modlin RL, Kronenberg M. Naidenko OV, et al. J Exp Med. 1999 Oct 18;190(8):1069-80. doi: 10.1084/jem.190.8.1069. J Exp Med. 1999. PMID: 10523605 Free PMC article.

2

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Matsuda JL, et al. Among authors: naidenko ov. J Exp Med. 2000 Sep 4;192(5):741-54. doi: 10.1084/jem.192.5.741. J Exp Med. 2000. PMID: 10974039 Free PMC article.

3

The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.

Sidobre S, Naidenko OV, Sim BC, Gascoigne NR, Garcia KC, Kronenberg M. Sidobre S, et al. Among authors: naidenko ov. J Immunol. 2002 Aug 1;169(3):1340-8. doi: 10.4049/jimmunol.169.3.1340. J Immunol. 2002. PMID: 12133957

4

Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer.

Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS, Koning F, Mikayama T, Van De Water J, Coppel RL, Kaplan M, Gershwin ME. Kita H, et al. Among authors: naidenko ov. Gastroenterology. 2002 Oct;123(4):1031-43. doi: 10.1053/gast.2002.36020. Gastroenterology. 2002. PMID: 12360465

5

Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.

Sakai T, Naidenko OV, Iijima H, Kronenberg M, Koezuka Y. Sakai T, et al. Among authors: naidenko ov. J Med Chem. 1999 May 20;42(10):1836-41. doi: 10.1021/jm990054n. J Med Chem. 1999. PMID: 10346936

6

CD1-mediated antigen presentation of glycosphingolipids.

Naidenko OV, Koezuka Y, Kronenberg M. Naidenko OV, et al. Microbes Infect. 2000 May;2(6):621-31. doi: 10.1016/s1286-4579(00)00363-4. Microbes Infect. 2000. PMID: 10884613 Free article. Review.

7

The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L. Hong S, et al. Among authors: naidenko ov. Nat Med. 2001 Sep;7(9):1052-6. doi: 10.1038/nm0901-1052. Nat Med. 2001. PMID: 11533710

8

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.

Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC. Metelitsa LS, et al. Among authors: naidenko ov. J Immunol. 2001 Sep 15;167(6):3114-22. doi: 10.4049/jimmunol.167.6.3114. J Immunol. 2001. PMID: 11544296

9

Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.

Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T, Kronenberg M. Brossay L, et al. J Immunol. 1998 Nov 15;161(10):5124-8. J Immunol. 1998. PMID: 9820479

10

Glycolipid antigen processing for presentation by CD1d molecules.

Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A, Natori T, Koezuka Y, Kulkarni A, Kronenberg M. Prigozy TI, et al. Science. 2001 Jan 26;291(5504):664-7. doi: 10.1126/science.291.5504.664. Science. 2001. PMID: 11158680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters